Amedeo Smart

Free Medical Literature Service


 

Amedeo

Multiple Sclerosis

  Free Subscription

Articles published in
N Engl J Med
    May 2021
  1. GIBBONS MD, Mendoza DP, Waheed A, Barshak MB, et al
    Case 14-2021: A 64-Year-Old Woman with Fever and Pancytopenia.
    N Engl J Med. 2021;384:1849-1857.
    >> Share

    February 2021
  2. GOVERMAN JM
    Regulatory T Cells in Multiple Sclerosis.
    N Engl J Med. 2021;384:578-580.
    >> Share

    January 2021
  3. ZAMVIL SS, Hauser SL
    Antigen Presentation by B Cells in Multiple Sclerosis.
    N Engl J Med. 2021;384:378-381.
    >> Share

    August 2020
  4. HAUSER SL, Bar-Or A, Cohen JA, Comi G, et al
    Ofatumumab versus Teriflunomide in Multiple Sclerosis.
    N Engl J Med. 2020;383:546-557.
    >> Share

    October 2019
  5. TUNKEL AR, Baron EL, Buch KA, Marty FM, et al
    Case 31-2019: A 45-Year-Old Woman with Headache and Somnolence.
    N Engl J Med. 2019;381:1459-1470.
    >> Share

    May 2019
  6. IEZZONI LI
    Dangers of Diagnostic Overshadowing.
    N Engl J Med. 2019;380:2092-2093.
    >> Share

  7. MONTALBAN X, Arnold DL, Weber MS, Staikov I, et al
    Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis.
    N Engl J Med. 2019 May 10. doi: 10.1056/NEJMoa1901981.
    >> Share

    September 2018
  8. ANTEL J
    Therapy in Multiple Sclerosis - Coming of Age.
    N Engl J Med. 2018;379:1085-1086.
    >> Share

  9. CHITNIS T, Arnold DL, Banwell B, Bruck W, et al
    Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis.
    N Engl J Med. 2018;379:1017-1027.
    >> Share

    August 2018
  10. FOX RJ, Coffey CS, Conwit R, Cudkowicz ME, et al
    Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.
    N Engl J Med. 2018;379:846-855.
    >> Share

    January 2018
  11. REICH DS, Lucchinetti CF, Calabresi PA
    Multiple Sclerosis.
    N Engl J Med. 2018;378:169-180.
    >> Share

    August 2017
  12. METZ LM, Eliasziw M
    Trial of Minocycline in Clinically Isolated Syndrome of Multiple Sclerosis.
    N Engl J Med. 2017;377:789.
    >> Share


  13. Trial of Minocycline in Clinically Isolated Syndrome of Multiple Sclerosis.
    N Engl J Med. 2017;377:788-789.
    >> Share

    June 2017
  14. XIA Z, Friedlander RM
    Minocycline in Multiple Sclerosis - Compelling Results but Too Early to Tell.
    N Engl J Med. 2017;376:2191-2193.
    >> Share

  15. METZ LM, Li DKB, Traboulsee AL, Duquette P, et al
    Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis.
    N Engl J Med. 2017;376:2122-2133.
    >> Share

    April 2017
  16. DEISENHAMMER F, Auer M, Hegen H
    Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
    N Engl J Med. 2017;376:1693-4.
    >> Share

  17. MILDINER S, Malnick S
    Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
    N Engl J Med. 2017;376:1692-3.
    >> Share

  18. SHARP MK
    Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
    N Engl J Med. 2017;376:1692.
    >> Share

  19. KORN T, Oukka M
    A BAFFling Association between Malaria Resistance and the Risk of Multiple Sclerosis.
    N Engl J Med. 2017;376:1680-1681.
    >> Share

  20. MONTALBAN X, Belachew S, Wolinsky JS
    Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
    N Engl J Med. 2017;376:1694.
    >> Share

  21. SCHOERGENHOFER C, Jilma B
    Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
    N Engl J Med. 2017;376:1693.
    >> Share

  22. HAUSER SL, Belachew Sh, Kappos L
    Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
    N Engl J Med. 2017;376:1694.
    >> Share

  23. STERI M, Orru V, Idda ML, Pitzalis M, et al
    Overexpression of the Cytokine BAFF and Autoimmunity Risk.
    N Engl J Med. 2017;376:1615-1626.
    >> Share

    December 2016
  24. MONTALBAN X, Hauser SL, Kappos L, Arnold DL, et al
    Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.
    N Engl J Med. 2016 Dec 21. doi: 10.1056/NEJMoa1606468.
    >> Share

  25. HAUSER SL, Bar-Or A, Comi G, Giovannoni G, et al
    Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
    N Engl J Med. 2016 Dec 21. doi: 10.1056/NEJMoa1601277.
    >> Share

  26. CALABRESI PA
    B-Cell Depletion - A Frontier in Monoclonal Antibodies for Multiple Sclerosis.
    N Engl J Med. 2016 Dec 21. doi: 10.1056/NEJMe1614717.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016